Analyst
OrbiMed
Equibles does not estimate personal net worth.
Girish Bakhru is recorded as Analyst at OrbiMed. Girish Bakhru has spoken on 1 earnings call across 1 company, most recently for Sun Pharmaceutical Industries Limited on May 22, 2026. The companies whose calls Girish Bakhru spoke on are classified in the Healthcare sector.
“Just some commentary on biosimilar Stellara impact. I know it's in a different channel, but discounts are very heavy, almost going to 90%. And there have been significant formulary exclusion of branded Stellara.”
OrbiMed
Analyst
Transcript header (unverified)
Sun Pharmaceutical Industries Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Sun Pharma Q4 FY26 Earnings Call Transcript
Sun Pharmaceutical Industries Limited
